Targeting chemokines and chemokine receptors with antibodies

Download Type: Adobe PDF

Chemokines and their receptors are highly interesting therapeutic targets for pharmaceutical and biotechnology companies. In particular, industrial development pipelines are filled with new chemokine-targeting drugs to treat inflammatory diseases and malignancies.

In this review, Klarenbeek et al. specifically highlight antibody-based therapeutics and monoclonal antibodies (mAbs) targeting the chemokine system. Besides discussing pitfalls inherently linked to their discovery, they elaborate on where progress can be made in the development of novel human therapeutic antibodies directed at the chemokine system.

Share this download

More services